Investigation Overview
October 21, 2013 (Shareholders Foundation) - An investigation on behalf of investors of Amarin Corporation plc (ADR) (NASDAQ:AMRN) shares over potential securities laws violations by Amarin and certain of its directors and officers in connection certain statements over its drug Vascepa was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers o...
You must register (for free) or login to view the entire investigation.